ArticlemSphere2021
Inhibition of Three Potato Pathogens by Phenazine-Producing
Article in mSphere, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 32 citations in OpenAlex.
- Mining Actinomycetes' Metabolomes and Genomes for Anti-Phytophthora infestans Compounds.Microbial biotechnology · 2025Article
- Quorum sensing modulates microbial community structure through regulation of secondary metabolites.mSphere · 2025Article
- Investigation of the mechanisms involved in the biocontrol activities of natural products from a marine soil bacterium against rice blast.Pest management science · 2025Article
- Biocontrol and Growth Promotion of Rice byJournal of microbiology and biotechnology · 2025Article
- A novel high-throughput screen identifies phenazine-1-carboxylic acid as an inhibitor of African swine fever virus replication in primary porcine alveolar macrophages.Veterinary research · 2025Article
- Unveiling the multifaceted potential ofMicrobiology spectrum · 2024Article
- Optimized CRISPR Interference System for InvestigatingACS synthetic biology · 2024Article
- Biotechnological potential of psychrotolerant methylobacteria isolated from biotopes of Antarctic oases.Archives of microbiology · 2024Article
- Effects of blister blight disease on endophytic microbial diversity and community structure in tea (3 Biotech · 2023Article
- 2,4-Diacetylphloroglucinol producing3 Biotech · 2022Article
- Interplay betweenMicroorganisms · 2022Article
- Harnessing the genomic diversity ofFrontiers in microbiology · 2022Article
- Decoding the Plant Growth Promotion and Antagonistic Potential of Bacterial Endophytes FromFrontiers in plant science · 2022Article
- In Tuber Biocontrol of Potato Late Blight by a Collection of Phenazine-1-Carboxylic Acid-ProducingMicroorganisms · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Phenazine-producing Pseudomonas spp. are effective biocontrol agents that aggressively colonize the rhizosphere and suppress numerous plant diseases. In this study, we compared the ability of 63 plant-beneficial phenazine-producing Pseudomonas strains representative of the worldwide diversity to inhibit the growth of three major potato pathogens: the oomycete Phytophthora infestans, the Gram-positive bacterium Streptomyces scabies, and the ascomycete Verticillium dahliae. The 63 Pseudomonas strains are distributed among four different subgroups within the P. fluorescens species complex and produce different phenazine compounds, namely, phenazine-1-carboxylic acid (PCA), phenazine-1-carboxamide (PCN), 2-hydroxyphenazine-1-carboxylic acid, and 2-hydroxphenazine. Overall, the 63 strains exhibited contrasted levels of pathogen inhibition. Strains from the P. chlororaphis subgroup inhibited the growth of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.